CDH1 and colorectal carcinoma: In contrast, the literature on β-catenin and E-cadherin has been clouded by many conflicting findings due to a large number of unstandardized and underpowered studies (17, 18, 21, 24–38), and their potential as biomarkers in CRC still merits further investigation.